Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ALDX will decline by -73.05% over the next 2 Weeks and hit $0.45 by Thursday, April 16, 2026. In that time frame, ALDX's share price is expected to range between $0.00 and $1.49.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Apr 16, 2026 | 0.00 | 0.41 | 1.44 |
| Apr 15, 2026 | 0.00 | 0.35 | 1.39 |
| Apr 14, 2026 | 0.00 | 0.47 | 1.55 |
| Apr 13, 2026 | 0.00 | 1.07 | 2.10 |
| Apr 10, 2026 | 0.00 | 0.97 | 2.02 |
| Apr 9, 2026 | 0.00 | 1.03 | 2.11 |
| Apr 8, 2026 | 0.00 | 0.96 | 1.98 |
| Apr 7, 2026 | 0.10 | 1.09 | 2.19 |
| Apr 6, 2026 | 0.64 | 1.69 | 2.69 |
| Apr 3, 2026 | 0.50 | 1.59 | 2.64 |
ALDX shares fell -1.19% in Thursday, April 2, 2026's trading session, dropping from a previous close of $1.68 to move at $1.66. The stock demonstrated notable intraday movement (see ALDX's key stats for a full breakdown), fluctuating between $1.63 and $1.72, a +5.52% trading range. While recent weeks have seen some volatility, ALDX has managed to secure a -9.29% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 1.81M shares changing hands, 2.73M fewer than the previous session. This amounted to $3.00M in total market activity.
Will ALDX Continue Its Downward Trend?
According to analyst ratings and projections for ALDX, Aldeyra Therapeutics, Inc. shares are anticipated to decrease by -15.06%, potentially reaching $1.44 per share by April 16, 2026. Short-term technical indicators for ALDX currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 18 negative trading days within the past 30 sessions. Based on the ALDX stock forecast, now is not the best time to buy ALDX stock because its current trading price is +301.84% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on ALDX covering social and institutional perspectives.
ALDX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ALDX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 26.83% to 30.51%) suggest the stock is experiencing strong bearish momentum. The 50-day RSI, at 37.42%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 42.28%, maintains a neutral outlook for the long term. Insights into ALDX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Aldeyra Therapeutics Short-Term Forecasts
ALDX Forecast For Next 5 Days
Our algorithm anticipates Aldeyra Therapeutics (ALDX) stock could hit $0.79 by Apr 10, 2026. This represents a -52.42% rise from today's price, following a +15.01% change over the past five days.
ALDX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Aldeyra Therapeutics, Inc. (ALDX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.39, which would mean a -76.51% decrease from the current price of $1.66. Projections for this period range from a high of $1.73 to a low of $0.00.
ALDX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Aldeyra Therapeutics's price over the next three months point to a rise. ALDX stock is expected to peak at $5.15 on Apr 30, 2026 before potentially dipping to $0.76 on Jul 01, 2026. On average, ALDX is likely to trade around $3.69 in the coming 90 days.
Aldeyra Therapeutics Stock Forecast 2025
Based on our predictive models, Aldeyra Therapeutics (ALDX) is expected to trade between $0.00 and $5.15 throughout 2026. This would result in an average price of $3.41, potentially offering investors a +105.42% return from current levels.
Aldeyra Therapeutics, Inc. Monthly Forecast 2026–2027
April 2026
According to our latest forecast models, Aldeyra Therapeutics, Inc. (ALDX) is positioned to show a strong performance in April 2026. The price is predicted to move between $3.12 and $5.15, settling at an average of $4.04. This could translate to a +143.37% gain.
May 2026
Based on current market signals, Aldeyra Therapeutics, Inc. is projected to trend may 2026. We forecast a trading range from $3.68 to $5.10, with a likely average price of $4.43. Investors could expect a potential return of +166.87%.
June 2026
Our predictive algorithms indicate Aldeyra Therapeutics, Inc. stock may see a shift in June 2026. The expected range spans $0.82–$4.39, with an average target of $3.03. This represents a positive outlook and a possible gain of +82.53%.
July 2026
Analyzing established trends, Aldeyra Therapeutics, Inc. looks set to move in July 2026. Projections place the stock between $0.76 and $3.46, averaging around $2.34. This suggests a +40.96% gain from current levels.
August 2026
Market indicators suggest Aldeyra Therapeutics, Inc. could experience notable changes during August 2026. Prices could fluctuate within $1.80 to $3.93, with a midpoint forecast of $3.27. The stock might deliver a +96.99% gain.
September 2026
Forecasting for September 2026, models estimate that Aldeyra Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $1.56 and $4.99, averaging $3.93. This signals a positive trajectory with potential returns around +136.75%.
October 2026
According to our latest forecast models, Aldeyra Therapeutics, Inc. (ALDX) is positioned to show a strong performance in October 2026. The price is predicted to move between $0.47 and $4.89, settling at an average of $3.83. This could translate to a +130.72% gain.
November 2026
Based on current market signals, Aldeyra Therapeutics, Inc. is projected to trend november 2026. We forecast a trading range from $0.00 to $4.37, with a likely average price of $3.20. Investors could expect a potential return of +92.77%.
December 2026
Our predictive algorithms indicate Aldeyra Therapeutics, Inc. stock may see a shift in December 2026. The expected range spans $0.00–$3.49, with an average target of $2.84. This represents a positive outlook and a possible gain of +71.08%.
January 2027
Analyzing established trends, Aldeyra Therapeutics, Inc. looks set to move in January 2027. Projections place the stock between $0.00 and $3.19, averaging around $2.70. This suggests a +62.65% gain from current levels.
February 2027
Market indicators suggest Aldeyra Therapeutics, Inc. could experience notable changes during February 2027. Prices could fluctuate within $0.00 to $4.33, with a midpoint forecast of $3.19. The stock might deliver a +92.17% gain.
March 2027
Forecasting for March 2027, models estimate that Aldeyra Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $4.24, averaging $2.95. This signals a positive trajectory with potential returns around +77.71%.
April 2027
According to our latest forecast models, Aldeyra Therapeutics, Inc. (ALDX) is positioned to show a strong performance in April 2027. The price is predicted to move between $0.00 and $3.82, settling at an average of $2.58. This could translate to a +55.42% gain.
ALDX's history of dividends and stock splits also plays a role in long-term investor confidence.